論文

• Community-based HbA1c testing programme for early detection of undiagnosed diabetes in community pharmacy
  Aiko Shono; Aki Morihiro; Nobue Harada; Xerxes Seposo; Wataru Mimura; Shu-ling Hoshi; Naoya Yahagi; Seiko Miyazaki; Masahide Kondo
  International Journal of Pharmacy Practice, 2025年02月12日

  URL
• Liver function trends in children with suspected drug‐induced hepatocellular injury: A survey using an electronic medical records database
  Masayoshi Nakakuni; Kosuke Nakano; Ayano Inui; Shinji Kobayashi; Naoko Deguchi; Seiji Mitsui; Takeshi Kuriyama; Seiko Miyazaki
  Pediatrics International, 2025年01月

  URL
• Investigation on the accumulation of background and pregnancy outcome information on cases consulted by the Japan Drug Information Institute in Pregnancy.
  Naho Yakuwa; Atsuko Murashima; Seiko Miyazaki
  Congenital anomalies, 2024年01月
• Analysis of safety specifications in risk management plan at the time of drug approval and addition of clinically significant adverse reactions in the package insert post-approval in Japan.
  Rieko Saito; Seiko Miyazaki
  Pharmacology research & perspectives, 2023年08月
• Comparison of Addition of Indications for Antineoplastic Agents Approved in the United States and Japan from 2001 to 2020.
  Toshiyuki Shizuya; Seiko Miyazaki
  Biological & pharmaceutical bulletin, 2023年
• Comparative Study of General Notices in Pharmacopoeias in Japan, the United States, and Europe
  Koko Tanaka; Rieko Saito; Maki Matsuhama; Seiko Miyazaki
  Chemical and Pharmaceutical Bulletin, 2023年01月01日
• Comparison of New Drug Indications Approved in the United States, Europe, and Japan from 2001 to 2020
  Toshiyuki Shizuya; Seiko Miyazaki
  Biological and Pharmaceutical Bulletin, 2022年10月01日
• [Survey on the Provision of Drug Information by Pharmacists to Lactating Women].
  Seiko Miyazaki
  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2022年
• Antihypertensive drug effects according to the pretreatment self-measured home blood pressure: the HOMED-BP study
  Hikari Sano; Azusa Hara; Kei Asayama; Seiko Miyazaki; Masahiro Kikuya; Yutaka Imai; Takayoshi Ohkubo
  BMJ Open, 2020年12月
• Development of a Logic Model for Promoting Incorporation of the Concepts of Impurity-Related ICH Guidelines into Pharmacopoeias Based on Cause and Effect Analysis
  Maki Matsuhama; Rieko Saito; Seiko Miyazaki
  Chemical and Pharmaceutical Bulletin, 2020年11月01日
• 入院治療を要した多形紅斑型薬疹, 播種状紅斑丘疹型薬疹の原因薬剤の傾向分析
  生子 宮崎; 舞 平木; 樹里 小山; 幹子 藤山
  日本皮膚免疫アレルギー学会雑誌, 2020年10月30日
• Blood Pressure Phenotypes Defined by Ambulatory Blood Pressure Monitoring and Carotid Artery Changes in Community-Dwelling Older Japanese Adults: The Ohasama Study
  Ayami Fujita; Azusa Hara; Masahiro Kikuya; Kei Asayama; Michihiro Satoh; Kaori Asakura; Yoriko Shintani; Shinya Uchida; Yuko Takatsuji; Takahisa Murakami; Takuo Hirose; Megumi Tsubota-Utsugi; Ryusuke Inoue; Kyoko Nomura; Hirohito Metoki; Atsushi Hozawa; Seiko Miyazaki; Yutaka Imai; Takayoshi Ohkubo
  The Tohoku Journal of Experimental Medicine, 2020年
• Comparative Study of Pharmacopoeias in Japan, Europe, and the United States: Toward the Further Convergence of International Pharmacopoeial Standards
  Yujiro Kameyama; Maki Matsuhama; Chie Mizumaru; Rieko Saito; Tsuyoshi Ando; Seiko Miyazaki
  Chemical and Pharmaceutical Bulletin, 2019年12月01日
• Regulatory convergence of medical devices: a case study using ISO and IEC standards
  Kuniki Imagawa; Yoshiaki Mizukami; Seiko Miyazaki
  Expert Review of Medical Devices, 2018年07月03日
• 日本薬局方, 米国薬局方および欧州薬局方の比較検討―構成, 通則および不純物の管理について―
  万貴 松濵; 智絵 水丸; 生子 宮崎
  レギュラトリーサイエンス学会誌, 2018年
• The Japanese Postmarketing Adverse Event Relief System: A Confluence of Regulatory Science, the Legal System, and Clinical Pharmacology
  T Tominaga; S Miyazaki; Y Oniyama; AD Weber; T Kondo
  Clinical Pharmacology & Therapeutics, 2017年08月
• 日本薬局方（JP）130 周年記念シンポジウムと JP18 に向けた今後の課題
  恭一 伹野; 喜代志 酒井; 生子 宮崎
  薬史学雑誌, 2017年
• Immunochemical characterization of anti-H monoclonal antibodies obtained from a mouse immunized with human saliva
  Working Group on Guidelines for Monitoring and Auditing Clinical Trials
  Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics, 2015年
• [Relief system for adverse drug reactions].
  Seiko Miyazaki
  Nihon rinsho. Japanese journal of clinical medicine, 2012年08月
• [Adverse health effect relief services].
  Junko Sato; Seiko Miyazaki
  Nihon rinsho. Japanese journal of clinical medicine, 2007年10月28日
• ABO Antigens in Red Cells and Digestive Organs of Non-human Primates
  Tamiko NAKAJIMA; Seike MIYAZAKI; Shin YAZAWA; K. FURUKAWA; Osamu TAKENAKA
  Primate Research, 1989年